These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 23517670

  • 1. EVI1 splice variants modulate functional responses in ovarian cancer cells.
    Dutta P, Bui T, Bauckman KA, Keyomarsi K, Mills GB, Nanjundan M.
    Mol Oncol; 2013 Jun; 7(3):647-68. PubMed ID: 23517670
    [Abstract] [Full Text] [Related]

  • 2. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
    Nanjundan M, Nakayama Y, Cheng KW, Lahad J, Liu J, Lu K, Kuo WL, Smith-McCune K, Fishman D, Gray JW, Mills GB.
    Cancer Res; 2007 Apr 01; 67(7):3074-84. PubMed ID: 17409414
    [Abstract] [Full Text] [Related]

  • 3. Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.
    Sayadi A, Jeyakani J, Seet SH, Wei CL, Bourque G, Bard FA, Jenkins NA, Copeland NG, Bard-Chapeau EA.
    Oncogene; 2016 May 05; 35(18):2311-21. PubMed ID: 26234679
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of EVI1 and EVI1s (Delta324) as potential therapeutic targets in ovarian cancer.
    Jazaeri AA, Ferriss JS, Bryant JL, Dalton MS, Dutta A.
    Gynecol Oncol; 2010 Aug 01; 118(2):189-95. PubMed ID: 20462630
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
    Maicas M, Vázquez I, Alis R, Marcotegui N, Urquiza L, Cortés-Lavaud X, Cristóbal I, García-Sánchez MA, Odero MD.
    Biochim Biophys Acta Gene Regul Mech; 2017 Jun 01; 1860(6):721-729. PubMed ID: 28391050
    [Abstract] [Full Text] [Related]

  • 10. Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects.
    Bard-Chapeau EA, Szumska D, Jacob B, Chua BQ, Chatterjee GC, Zhang Y, Ward JM, Urun F, Kinameri E, Vincent SD, Ahmed S, Bhattacharya S, Osato M, Perkins AS, Moore AW, Jenkins NA, Copeland NG.
    PLoS One; 2014 Jun 01; 9(2):e89397. PubMed ID: 24586749
    [Abstract] [Full Text] [Related]

  • 11. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide.
    Singh S, Pradhan AK, Chakraborty S.
    Biochim Biophys Acta; 2013 Oct 01; 1833(10):2357-68. PubMed ID: 23770046
    [Abstract] [Full Text] [Related]

  • 12. Ecotropic viral integration site 1, a novel oncogene in prostate cancer.
    Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, Deng M, Vogel W, von Mässenhausen A, Kristiansen G, Duensing S, Kirfel J, Lengerke C, Perner S.
    Oncogene; 2017 Mar 01; 36(11):1573-1584. PubMed ID: 27617580
    [Abstract] [Full Text] [Related]

  • 13. [The role and regulation of EVI1 in normal hematopoiesis and hematopoietic malignancies].
    Masamoto Y.
    Rinsho Ketsueki; 2024 Mar 01; 65(9):954-960. PubMed ID: 39358295
    [Abstract] [Full Text] [Related]

  • 14. Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration.
    Haas K, Kundi M, Sperr WR, Esterbauer H, Ludwig WD, Ratei R, Koller E, Gruener H, Sauerland C, Fonatsch C, Valent P, Wieser R.
    Genes Chromosomes Cancer; 2008 Apr 01; 47(4):288-98. PubMed ID: 18181178
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. EVI1 overexpression promotes ovarian cancer progression by regulating estrogen signaling.
    Wang Z, Li Y, Wang N, Li P, Kong B, Liu Z.
    Mol Cell Endocrinol; 2021 Aug 20; 534():111367. PubMed ID: 34146645
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.